The team hopes to develop a model that will estimate a patient's risk of major cardiovascular events and predict when such events are most likely to occur.

The cardiac radiologist and associate professor at the University of Toronto offered insights into key themes from the conference. 

FDA Commissioner Robert Califf, MD, explains the need for hospitals to perform quality assurance checks on clinical artificial intelligence to ensure these technologies don't "drift" from what was originally cleared by the FDA.